In:
Renal Replacement Therapy, Springer Science and Business Media LLC, Vol. 8, No. 1 ( 2022-12-02)
Kurzfassung:
We examined the clinical characteristics of hemodialysis patients with COVID-19 during the 6th wave of infection (mainly Omicron variant) in Japan. Methods Hemodialysis patients admitted in January 2022 and thereafter were grouped as the 6th wave group ( n = 53), while others were grouped as the 1st–5th wave group ( n = 47). Results The proportion of vaccinations was significantly higher in the 6th wave group than in the 1st–5th wave group (96.2% vs 10.6%, p 〈 0.0001). Neutralizing antibody and molnupiravir were used more frequently in the 6th wave group (75.5% and 88.7%) than in the 1st–5th wave group (14.9% and 0%, both p 〈 0.0001). The critical disease was seen in 21.3% of the patients in the 1st–5th wave group and 0% in the 6th wave group ( p 〈 0.001). Conclusion The prognosis of hemodialysis patients in the 6th wave group was good. The vaccination and advances in the treatment may have contributed to the outcomes.
Materialart:
Online-Ressource
ISSN:
2059-1381
DOI:
10.1186/s41100-022-00451-2
Sprache:
Englisch
Verlag:
Springer Science and Business Media LLC
Publikationsdatum:
2022
ZDB Id:
2866852-2
